PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST
2024-11-27 | Pages: 200+ | Report ID: MD-R-2024-11-27-35431 | Healthcare
Historical data: 2018 - 2023
Forecast period: 2024 - 2031
Quantitative units: Revenue in USD million and CAGR from 2024 to 2031
Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Predictive Genetic Testing & Consumer/Wellness Genomics Market
1.1 SCOPE OF THE REPORT
1.2 MARKET SEGMENT ANALYSIS
1.3 REGULATORY SCENARIO BY REGION/COUNTRY
1.4 MARKET INVESTMENT SCENARIO STRATEGIC
1.5 MARKET ANALYSIS BY TYPE (USD MILLION)
1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)
2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS
2.1.1 MARKET DRIVER ANALYSIS
2.1.2 MARKET RESTRAINT ANALYSIS
2.1.3 MARKET OPPORTUNITY
2.1.4 MARKET CHALLENGES
3.1 INDUSTRY TRENDS
3.1.1 SWOT ANALYSIS
3.1.2 PESTEL ANALYSIS
3.1.3 PORTER’S FIVE FORCES ANALYSIS
3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS
4.1 COVID-19 ANALYSIS
5.1 GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, SALES AREA, TYPE
5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET
7.1 GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SIZE AND SHARE (2018-2031) (USD MILLION)
8.1 GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
8.2 GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
9.1 GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
9.2 GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
10.1 GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SIZE AND SHARE BY REGION (2018-2023) (USD MILLION)
10.2 GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SIZE AND SHARE BY REGION (2024-2031) (USD MILLION)
11.1 NORTH AMERICA PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
11.2 NORTH AMERICA PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
11.3 NORTH AMERICA PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
11.4 NORTH AMERICA PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
11.5 NORTH AMERICA PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
11.6 NORTH AMERICA PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
12.1 EUROPE PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
12.2 EUROPE PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
12.3 EUROPE PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
12.4 EUROPE PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
12.5 EUROPE PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
12.6 EUROPE PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
13.1 ASIA PACIFIC PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
13.2 ASIA PACIFIC PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
13.3 ASIA PACIFIC PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
13.4 ASIA PACIFIC PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
13.5 ASIA PACIFIC PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
13.6 ASIA PACIFIC PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
14.1 LATIN AMERICA PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)/p>
14.2 LATIN AMERICA PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
14.3 LATIN AMERICA PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
14.4 LATIN AMERICA PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
14.5 LATIN AMERICA PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
14.6 LATIN AMERICA PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
15.1 MIDDLE EAST & AFRICA PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
15.2 MIDDLE EAST & AFRICA PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
15.3 MIDDLE EAST & AFRICA PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
15.4 MIDDLE EAST & AFRICA PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
15.5 MIDDLE EAST & AFRICA PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
15.6 MIDDLE EAST & AFRICA PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SIZE AND SHARE BY APPLICATION (2024-2031)< (USD MILLION)/p>
16.1 ARUP Laboratories
16.1.1 COMPANY DETAILS
16.1.2 FINANCIALS (USD MILLION)
16.1.3 PRODUCT SUMMARY
16.1.4 RECENT DEVELOPMENTS
16.2 Bio-Rad Laboratories Inc
16.3 BGI
16.4 Genesis Genetics
16.5 Thermo Fisher Scientific Inc
16.6 3andMe Inc
16.7 Abbott Laboratories
16.8 F Hoffmann-La Roche Ltd
16.9 Myriad Genetics Inc
16.10 Agilent Technologies
16.11 Illumina Inc
16.12 Counsyl Inc
18.1 METHODOLOGY
18.2 RESEARCH DATA SOURCE
18.2.1 SECONDARY DATA
18.2.2 KEY DATA FROM SECONDARY
18.2.3 PRIMARY DATA
18.2.4 KEY DATA FROM PRIMARY
18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS
18.2.6 MARKET ESTIMATION
18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH
18.2.8 LEGAL DISCLAIMER
Market Segments
By TypePredictive Testing
Consumer Genomics
Wellness Genomics
By Application
Breast & Ovarian Cancer
Cardiovascular screening
Diabetic Screening & Monitoring
Colon Cancer
Parkinsonism / AlzheimerÂ’s Disease
Urologic screening/ Prostate cancer screening
Orthopedic & Musculoskeletal
Other cancer screening
Other diseases
Companies
ARUP Laboratories
Bio-Rad Laboratories Inc
BGI
Genesis Genetics
Thermo Fisher Scientific Inc
3andMe Inc
Abbott Laboratories
F Hoffmann-La Roche Ltd
Myriad Genetics Inc
Agilent Technologies
Illumina Inc
Counsyl Inc
BROWSE INDUSTRY
- PROACTIVE
- QUALITY & RELIABILITY
- GLOBAL OUTREACH
- COMPETITIVE PRICING
WHY CHOOSE US
We manage our resources 24/7 to identify issues and address them before they become problems.
We are committed to providing reliable and highly accurate data with an excellent quality control system.
6 Major regions and 40+ countries level analysis accomplished.
Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.